Biotech · Private company
US Oncology Research
Track this companyFree. Adds US Oncology Research to your Dealase workspace and tells you when its record changes.
Clinical trials165 recruiting or active
Pipeline programs28From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline28
- BevacizumabPhase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- DoxorubicinPhase 3 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- FluorouracilPhase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- LeucovorinPhase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- OxaliplatinPhase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- AlisertibPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- BKM120Phase 2 · Brain MetastasesClinicalTrials.gov · fetched Nov 12, 2026
- capecitabinePhase 2 · Brain MetastasesClinicalTrials.gov · fetched Nov 12, 2026
- DaratumumabPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Dexamethasone OralPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Ibrutinib 420 mgPhase 2 · Breast NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Ibrutinib 560 mgPhase 2 · Breast NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Ibrutinib 840 mgPhase 2 · Breast NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Irinotecan + CarboplatinPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- irinotecan + Carboplatin + erbituxPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- LenalidomidePhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Miracle Mouthwash Plus HydrocortisonePhase 2 · StomatitisClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PertuzumabPhase 2 · Breast NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- PrednisolonePhase 2 · StomatitisClinicalTrials.gov · fetched Nov 12, 2026
- RegorafenibPhase 2 · Colorectal NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- SelinexorPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- TrastuzumabPhase 2 · Brain MetastasesClinicalTrials.gov · fetched Nov 12, 2026
- TrastuzumabPhase 2 · Breast NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Vinorelbine, Paclitaxel, Nab-Paclitaxel , Docetaxel, CapecitabinePhase 2 · Breast NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials16
- Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.UNKNOWN · started Jan 15, 2024ClinicalTrials.gov NCT06335758 · fetched Nov 12, 2026
- MYLUNG Consortium Part 3: Observational StudyRECRUITING · started Jan 30, 2023ClinicalTrials.gov NCT05885698 · fetched Nov 12, 2026
- Study of Selinexor Plus DRd for Newly Diagnosed Multiple MyelomaPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 10, 2021ClinicalTrials.gov NCT04782687 · fetched Nov 12, 2026
- MYLUNG Consortium Study Protocol 2ACTIVE_NOT_RECRUITING · started Dec 29, 2020ClinicalTrials.gov NCT05644808 · fetched Nov 12, 2026
- Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 29, 2017ClinicalTrials.gov NCT03379428 · fetched Nov 12, 2026
- Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOXPHASE2 · TERMINATED · started Mar 26, 2015ClinicalTrials.gov NCT02425683 · fetched Nov 12, 2026
- Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast CancerPHASE2 · COMPLETED · started Feb 12, 2015ClinicalTrials.gov NCT02187991 · fetched Nov 12, 2026
- Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast CancerPHASE2 · TERMINATED · started Dec 1, 2014ClinicalTrials.gov NCT02229149 · fetched Nov 12, 2026
- Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by EverolimusPHASE2 · COMPLETED · started Sep 4, 2014ClinicalTrials.gov NCT02229136 · fetched Nov 12, 2026
- STAR Cape+BKM120 MBC With Brain MetPHASE2 · COMPLETED · started May 29, 2014ClinicalTrials.gov NCT02000882 · fetched Nov 12, 2026
- A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast CancerPHASE3 · COMPLETED · started Apr 2, 2014ClinicalTrials.gov NCT02032277 · fetched Nov 12, 2026
- A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsPHASE3 · TERMINATED · started Feb 25, 2014ClinicalTrials.gov NCT01905592 · fetched Nov 12, 2026
- A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerPHASE3 · COMPLETED · started Jun 21, 2013ClinicalTrials.gov NCT01847274 · fetched Nov 12, 2026
- TAC Versus TC for Adjuvant Breast CancerPHASE3 · COMPLETED · started May 29, 2007ClinicalTrials.gov NCT00493870 · fetched Nov 12, 2026
- Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerPHASE3 · COMPLETED · started Sep 1, 2005ClinicalTrials.gov NCT00252564 · fetched Nov 12, 2026
- PhII ICb With/Without Erbitux in MBC PtsPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 28, 2005ClinicalTrials.gov NCT00248287 · fetched Nov 12, 2026